Female Stress Urinary Incontinence Treatment Devices Market Size & Share, by Type (Urethral Sling, Artificial Urinary Sphincters, Electrical Stimulation Devices, Catheters); Product Type (Sling Systems, Pessaries, Injectable Urethral Bulking Agents); End-user (Hospitals, Gynecological Clinics, Home Care Settings) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4376
  • Published Date: Feb 17, 2023
  • Report Format: PDF, PPT

Companies Dominating the Female Stress Urinary Incontinence Treatment Devices Landscape

    • Boston Scientific Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson Services, Inc.
    • Becton, Dickinson and Company
    • Coloplast Corp.
    • CooperSurgical, Inc.
    • MedGyn Products, Inc.
    • Caldera Medical, Inc
    • FEG Textiltechnik mbH
    • Medical Device Business Services, Inc.
    • Renovia Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • Renovia Inc., a leading company in the field of developing digital therapeutics for female pelvic floor disorders informed that Leva, a pelvic health system to treat women in urinary continence received acceptance from researchers supporting its value. It is stated that Leva can provide UI symptom improvement for 12 months and creates real-world data to increase its effectiveness.

  • Boston Scientific Corporation declared that Solyx, a single incision sling system succeeded in the treatment of women with stress urinary incontinence. It is designed to decrease dissection and provide a less complicated procedure.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4376
  • Published Date: Feb 17, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increase in instances of urinary incontinence and growing incidence of urinary incontinence due to menopause are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Emergence of neuromodulator for electric stimulation of nerves are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Coloplast Corp., CooperSurgical, Inc., MedGyn Products, Inc., Caldera Medical, Inc, FEG Textiltechnik mbH, Medical Device Business Services, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, product type, end-user, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying